Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma

The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study / Galimberti, S., Ciabatti, E., Ercolano, G., Grassi, S., Guerrini, F., Cecconi, N., Rousseau, M., Cervetti, G., Mazziotta, F., Iovino, L., Falzetti, F., Falcinelli, F., Bosi, A., Rigacci, L., Kovalchuk, S., Vallisa, D., Macchia, L., Ciancia, E., Petrini, M.. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - ELETTRONICO. - 8:(2017), pp. 25-30. [10.3389/fphar.2017.00413]

The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study

BOSI, ALBERTO;Kovalchuk, Sofia;
2017

Abstract

Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma
2017
8
25
30
Galimberti, Sara; Ciabatti, Elena; Ercolano, Giacomo; Grassi, Susanna; Guerrini, Francesca; Cecconi, Nadia; Rousseau, Martina; Cervetti, Giulia; Mazzi...espandi
1a - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
fphar-08-00413.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 452.17 kB
Formato Adobe PDF
452.17 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1089518
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact